The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

Walgreens is supporting the more than 56 million patients in the Medicare network that may be eligible for GLP-1 medications ...

CMS launches Medicare GLP-1 Bridge to offer select beneficiaries fixed-cost access to GLP-1 drugs from July 2026 through 2027.

For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the ...

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...

CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.

Healthcare providers, pharmacies, telehealth companies, and healthcare organizations should prepare for the launch of CMS’s Medicare GLP-1 Bridge, ...

Eli Lilly and Company (NYSE: LLY) today announced additional details regarding the Medicare GLP-1 Bridge* program taking ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...

(NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that Weight Watchers Med+ will support Medicare members seeking access to GLP-1 medications under ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. (Post updated on June 17, 2026, with new guidance from CMS.) There have been many headlines ...